This reference guide from the Lung Health Foundation provides a comprehensive list of respiratory medications and includes information about age, maximum dose, and coverage by ODB, EAP, and NIHB. Updated September 2021.
This guideline provides recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks to optimize maintenance pharmacological therapy for individuals with stable COPD, and a revised and practical treatment pathway based on new evidence since the 2019 update of the Canadian Thoracic Society (CTS) Guideline.
This guideline provides recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks to optimize maintenance pharmacological therapy for individuals with stable COPD, and a revised and practical treatment pathway based on new evidence since the 2019 update of the Canadian Thoracic Society (CTS) Guideline.
This handout summarizes the Canadian Thoracic Society (CTS) recommended approach to pharmacotherapy and how to assess for mortality risk using the ADO Index.
This handout summarizes the Canadian Thoracic Society (CTS) recommended approach to pharmacotherapy and how to assess for mortality risk using the ADO Index.
